

ACR24 - Day2c
Nov 18, 2024
Dr. Andrea Fava, a researcher specializing in autoimmune diseases, discusses groundbreaking research on fibroblasts and their role in conditions like lupus. She introduces an innovative urinary biomarker that could revolutionize lupus nephritis diagnosis. The podcast also highlights legislative efforts for better healthcare access and underscores the importance of monitoring cardiovascular health in autoimmune patients. Additionally, discussions touch on gender differences in disease management, advocating for tailored approaches to improve patient outcomes.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 2min
Revolutionizing Lupus Nephritis Diagnosis
02:06 • 9min
Assessing Cardiovascular Risks in Axial Spondyloarthritis
10:50 • 7min
Insights on Myocarditis Risks in Myositis Patients
17:54 • 2min
Navigating Gender Differences in Psoriatic Arthritis and Lupus Management
19:32 • 10min